{"organizations": [], "uuid": "a43672054fc9580162b080c5c3db1f8623d9c3e7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/15", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/26/globe-newswire-cambrex-to-announce-first-quarter-2018-financial-results-on-may-3-2018.html", "country": "US", "domain_rank": 767, "title": "Cambrex to Announce First Quarter 2018 Financial Results on May 3, 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.928, "site_type": "news", "published": "2018-04-26T23:15:00.000+03:00", "replies_count": 0, "uuid": "a43672054fc9580162b080c5c3db1f8623d9c3e7"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/26/globe-newswire-cambrex-to-announce-first-quarter-2018-financial-results-on-may-3-2018.html", "ord_in_thread": 0, "title": "Cambrex to Announce First Quarter 2018 Financial Results on May 3, 2018", "locations": [], "entities": {"persons": [], "locations": [{"name": "n.j.", "sentiment": "none"}, {"name": "rutherford", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "cambrex corporation", "sentiment": "negative"}, {"name": "nyse", "sentiment": "negative"}, {"name": "cambrex", "sentiment": "negative"}, {"name": "cambrex cambrex corporation", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "EAST RUTHERFORD, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that first quarter 2018 financial results will be released on Thursday, May 3, 2018 before the market opens.\nThe Company will host a conference call to discuss the financial results.\nFirst Quarter 2018 Earnings Conference Call When: Thursday, May 3, 2018 at 8:30 a.m. Eastern Time Dial-in: 1-877-260-1479 for U.S. 1-334-323-0522 for International Passcode: 5093025 Dial-in Replay: 1-888-203-1112 for U.S. 1-719-457-0820 for International Passcode: 5093025 Available through Thursday, May 10, 2018 Webcast: www.cambrex.com About Cambrex\nCambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and continuous processing. For more information, please visit www.cambrex.com .\nContact: Stephanie LaFiura Investor Relations Associate Tel: 201-804-3037 Email: stephanie.lafiura@cambrex.com\nSource:Cambrex Corporation", "external_links": ["https://www.globenewswire.com/NewsRoom/AttachmentNg/d35f6ab1-b0e4-47bc-bd70-26be3038407d", "https://www.globenewswire.com/Tracker?data=_YZGoa0Sulo_P_4-GH7PgeGlStfzfZvw-ibEZ-_tObNSvWqf6W1y9jw834c55ZumZo9jkJNj8Jj3zECn3WmItw=="], "published": "2018-04-26T23:15:00.000+03:00", "crawled": "2018-04-27T01:38:21.024+03:00", "highlightTitle": ""}